|
| |
| | | 59322 | | 03.09.2009 | | Sandoz Pharmaceuticals AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Crilomus 0.5 mg | Kapseln | Kapseln (Tacrolimus 0.5 mg) | L04AD02 | PI | | 02 | Crilomus 1 mg | Kapslen | Kapseln (Tacrolimus 1 mg) | L04AD02 | PI | | 03 | Crilomus 5 mg | Kapslen | Kapseln (Tacrolimus 5 mg) | L04AD02 | PI | | 04 | Crilomus 0.75 mg | Kapslen | Kapseln (Tacrolimus 0.75 mg) | L04AD02 | PI | | 05 | Crilomus 2 mg | Kapslen | Kapseln (Tacrolimus 2 mg) | L04AD02 | PI |
|
|
|
